One gene predicts rapid ALS progression 80 percent of the time

(Medical Xpress)—The debilitating symptoms of amyotrophic lateral sclerosis, or ALS, appear to be increased by a lack of inflammation-reducing T cells, report scientists from the Methodist Neurological Institute in an upcoming print issue of The EMBO Molecular Medicine Journal.The researchers found that expression of the gene FoxP3—which helps control the production of anti-inflammatory T cells—was an indicator of disease progression in 80 percent of the patients they studied. Low FoxP3 levels were likely in patients whose ALS would develop rapidly, and vice versa.

"This is the first demonstration that regulatory T cells may be slowing disease progression, since low FoxP3 indicates a rapidly progressing disease," said Assistant Professor of Neurology Jenny Henkel, Ph.D., the study's lead author. "Levels of FoxP3 may now be used as a prognostic indicator of future disease progression and survival."

ALS is a neurodegenerative disease that slowly and inexorably causes , then death. Loss of motor control may begin in the arms or legs, or with impaired speech, and ultimately compromise breathing. ALS is sometimes called Lou Gehrig's disease. About 5 in 100,000 people are affected, and there is no known cure.

The relationship between inflammation and ALS progression is well established in humans and animal models, and many genes influencing disease development have been identified.

"While inflammation exacerbates disease in ALS patients, this inflammation is suppressed in some patients," Henkel said. "The data in our article suggest that regulatory T cells can suppress this inflammation."

In their EMBO paper, Henkel, Professor of Neurology and Chair Stanley Appel, M.D., and their team provided supportive evidence that the genes FoxP3, TGFβ, IL4, and Gata3 are involved in ALS development. But Henkel and Appel's work also suggests FoxP3 is the best indicator of disease progression when ALS symptoms first appear.

"While expression of FoxP3, TGFβ, IL4, and Gata3 may serve as indicators for latter stages of the disease, our work suggests only FoxP3 was a early in the disease," Henkel said. "After following a group of ALS patients for three and a half years, low FoxP3 levels predicted a rapidly progressing disease 80 percent of the time."

Foxp3 and Gata3 are transcription factors that influence production of regulatory T cells, and Th2 "helper" T cells. TGFβ and IL-4 (interleukin 4) are anti-inflammatory cytokines.

Henkel, Appel, and their team studied three patient groups. In the first group, the researchers took blood samples from 54 ALS patients at different stages of the disease and from 33 healthy control volunteers. Flow cytometry and PCR were used to determine the character of white blood cells, specifically regulatory T cells, and to measure the expression levels of genes of interest. A second patient group (102 ALS, 28 healthy) was studied specifically to assess the predictive power of FoxP3 expression in ALS disease development. A third group consisting of deceased persons (affected and healthy) was studied for the purpose of establishing endpoints for T cell production and gene expression. Development of ALS was assessed using the Appel ALS score, a widely used standard that Appel developed.

The relationship between inflammation and ALS progression is complex. Inflammation is an important initial response to injury or microbial attack, Appel says, but prolonged inflammation can actually make the damage worse.

"While this inflammation is tolerable for the short term, when the inflammation persists, the pro-inflammatory cytokines and certain chemicals produced by glial cells called microglia will injure and eventually kill the surrounding neurons," Appel said. "Our research verifies that inflammation is accelerating disease progression, that regulatory T cells and Th2 may slow , and that modifying appears to be a viable treatment option."

Henkel and Appel said researchers are closing in on specific targets for modifying the that drives progression of the disease, and that they are closer than ever to developing new treatments for this severely debilitating condition.

Related Stories

Genetics of ALS progression

Jun 01, 2008

An upcoming paper in the June 1 issue of G&D, from Drs. Hidenori Ichijo and Hideki Nishitoh (University of Tokyo) and colleagues, lends new and valuable insight into the genetics of ALS.

Spinal fluid proteins signal Lou Gehrig's disease

Jan 28, 2009

High levels of certain proteins in the spinal fluid could signal the onset of Lou Gehrig's disease, according to researchers. The discovery of these biomarkers may lead to diagnostic kits for early diagnosis, accurately measuring ...

Recommended for you

A nucleotide change could initiate fragile X syndrome

15 hours ago

Researchers reveal how the alteration of a single nucleotide—the basic building block of DNA—could initiate fragile X syndrome, the most common inherited form of intellectual disability. The study appears ...

Gene clues to glaucoma risk

Aug 31, 2014

Scientists on Sunday said they had identified six genetic variants linked to glaucoma, a discovery that should help earlier diagnosis and better treatment for this often-debilitating eye disease.

Mutation disables innate immune system

Aug 29, 2014

A Ludwig Maximilian University of Munich team has shown that defects in the JAGN1 gene inhibit the function of a specific type of white blood cells, and account for a rare congenital immune deficiency that ...

Study identifies genetic change in autism-related gene

Aug 28, 2014

A new study from Bradley Hospital has identified a genetic change in a recently identified autism-associated gene, which may provide further insight into the causes of autism. The study, now published online in the Journal of ...

NIH issues finalized policy on genomic data sharing

Aug 27, 2014

The National Institutes of Health has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while ...

User comments